Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment

Condition:   Patient Satisfaction
Intervention:   Drug: Budesonide, Formoterol Fumarate Dihydrate
Sponsor:   Teva Pharma GmbH
Active, not recruiting – verified March 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days